HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
150755.0,276467,2131-12-25 06:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - START [**2131-12-25**] 05:24 AM
   Completed Aspirin desensitization protocol without problem (received
   Benadryl 25mg IV x1 for red itchy ears)
   Approx 1 hour after completion of protocol, developed severe
   respiratory distress, not responsive to steroids, H1- / H2- blockers,
   nebulizers, diuresis, or anxiolytics.
   Intubated, Art-line placed
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,450 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Lorazepam (Ativan) - [**2131-12-25**] 03:00 AM
   Propofol - [**2131-12-25**] 03:37 AM
   Furosemide (Lasix) - [**2131-12-25**] 04:21 AM
   Heparin Sodium - [**2131-12-25**] 05:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-25**] 06:54 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.5
   HR: 84 (79 - 132) bpm
   BP: 85/48(57) {85/48(57) - 159/103(117)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 65 Inch
             Total In:
                                                                     90 mL
                                                                    223 mL
   PO:
                                                                     60 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     30 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                  2,100 mL
                                                                    510 mL
   Urine:
                                                                  2,100 mL
                                                                    510 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,010 mL
                                                                   -287 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 500 (500 - 500) mL
   RR (Set): 15
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   PIP: 36 cmH2O
   Plateau: 21 cmH2O
   SpO2: 99%
   ABG: 7.35/51/429/32/1
   Ve: 7.9 L/min
   PaO2 / FiO2: 1,073
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   357 K/uL
   13.0 g/dL
   119 mg/dL
   1.0 mg/dL
   32 mEq/L
   3.9 mEq/L
   24 mg/dL
   103 mEq/L
   143 mEq/L
   38.5 %
   9.6 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
   WBC
   8.2
   9.6
   Hct
   35.0
   38.5
   Plt
   293
   357
   Cr
   0.9
   1.0
   TCO2
   32
   29
   Glucose
   106
   119
   Other labs: PT / PTT / INR:13.3/55.6/1.1, Differential-Neuts:84.6 %,
   Lymph:9.4 %, Mono:5.9 %, Eos:0.1 %, Lactic Acid:2.0 mmol/L, Ca++:9.1
   mg/dL, Mg++:2.3 mg/dL, PO4:3.5 mg/dL
   Assessment and Plan
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated overnight for acute-onset of severe
   respiratory distress that was non-responsive to treatment for
   anaphylaxis, COPD, CHF, or anxiety. Timing soon after completion of ASA
   desensitization protocol suggests anaphylactic reaction to the ASA,
   however the pt did not respond appropriately to treatment of such. He
   also did not respond to treatment of other possible causes of
   respiratory failure in the DDx.
   - check RSBI, attempt SBT and extubation today
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization
   - continue to treat CHF, COPD, and anxiety as below
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition: NPO for possible extubation, replete lytes PRN
   Glycemic Control:  well-controlled
   Lines:
   20 Gauge - [**2131-12-24**] 05:58 PM
   Arterial Line - [**2131-12-25**] 05:24 AM
   Prophylaxis:
   DVT: IV heparin gtt
   Stress ulcer: home PPI
   VAP:  mouth care
   Comments:
   Communication:  with pt and wife. Comments:
   [**Name2 (NI) 156**] status: FULL CODE
   Disposition: CCU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - START [**2131-12-25**] 05:24 AM
   Completed Aspirin desensitization protocol without problem (received
   Benadryl 25mg IV x1 for red itchy ears)
   Approx 1 hour after completion of protocol, developed severe
   respiratory distress, not responsive to steroids, H1- / H2- blockers,
   nebulizers, diuresis, or anxiolytics.
   Intubated, Art-line placed
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,450 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Lorazepam (Ativan) - [**2131-12-25**] 03:00 AM
   Propofol - [**2131-12-25**] 03:37 AM
   Furosemide (Lasix) - [**2131-12-25**] 04:21 AM
   Heparin Sodium - [**2131-12-25**] 05:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-25**] 06:54 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.5
   HR: 84 (79 - 132) bpm
   BP: 85/48(57) {85/48(57) - 159/103(117)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 65 Inch
             Total In:
                                                                     90 mL
                                                                    223 mL
   PO:
                                                                     60 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     30 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                  2,100 mL
                                                                    510 mL
   Urine:
                                                                  2,100 mL
                                                                    510 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,010 mL
                                                                   -287 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 500 (500 - 500) mL
   RR (Set): 15
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   PIP: 36 cmH2O
   Plateau: 21 cmH2O
   SpO2: 99%
   ABG: 7.35/51/429/32/1
   Ve: 7.9 L/min
   PaO2 / FiO2: 1,073
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   357 K/uL
   13.0 g/dL
   119 mg/dL
   1.0 mg/dL
   32 mEq/L
   3.9 mEq/L
   24 mg/dL
   103 mEq/L
   143 mEq/L
   38.5 %
   9.6 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
   WBC
   8.2
   9.6
   Hct
   35.0
   38.5
   Plt
   293
   357
   Cr
   0.9
   1.0
   TCO2
   32
   29
   Glucose
   106
   119
   Other labs: PT / PTT / INR:13.3/55.6/1.1, Differential-Neuts:84.6 %,
   Lymph:9.4 %, Mono:5.9 %, Eos:0.1 %, Lactic Acid:2.0 mmol/L, Ca++:9.1
   mg/dL, Mg++:2.3 mg/dL, PO4:3.5 mg/dL
   Assessment and Plan
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated overnight for acute-onset of severe
   respiratory distress that was non-responsive to treatment for
   anaphylaxis, COPD, CHF, or anxiety. Timing soon after completion of ASA
   desensitization protocol suggests anaphylactic reaction to the ASA,
   however the pt did not respond appropriately to treatment of such. He
   also did not respond to treatment of other possible causes of
   respiratory failure in the DDx.
   - check RSBI, attempt SBT and extubation today
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization
   - continue to treat CHF, COPD, and anxiety as below
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition: NPO for possible extubation, replete lytes PRN
   Glycemic Control:  well-controlled
   Lines:
   20 Gauge - [**2131-12-24**] 05:58 PM
   Arterial Line - [**2131-12-25**] 05:24 AM
   Prophylaxis:
   DVT: IV heparin gtt
   Stress ulcer: home PPI
   VAP:  mouth care
   Comments:
   Communication:  with pt and wife. Comments:
   [**Name2 (NI) 156**] status: FULL CODE
   Disposition: CCU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 73-year-old man with a history of chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), and recently diagnosed cardiomyopathy with an ejection fraction (EF) of 30%. He was admitted to the intensive care unit (ICU) for cardiac catheterization, which showed left-dominant system, LAD with diffuse 20-30% lesions, and LCx with mild luminal irregularities. The patient underwent aspirin desensitization protocol, but developed severe respiratory distress shortly after completion, which was not responsive to treatment for anaphylaxis, COPD, CHF, or anxiety. He was intubated and is currently receiving mechanical ventilation.

Assessment:

1. Respiratory failure: The patient is intubated for acute-onset severe respiratory distress of unknown etiology, which is not responsive to treatment for anaphylaxis, COPD, CHF, or anxiety.
2. Coronaries: The patient has left-dominant system, LAD with diffuse 20-30% lesions, and LCx with mild luminal irregularities.
3. Pump: The patient has recently diagnosed cardiomyopathy of unknown cause, with an EF of 20-25% and global LV HK and chamber dilation.
4. Rhythm: The patient has normal sinus rhythm (NSR) with left bundle branch block (LBBB) and frequent atrial premature contractions (APCs) and ventricular premature contractions (PVCs).
5. ASA allergy: The patient has ASA allergy with anaphylaxis, admitted to CCU for desensitization, and now s/p completed desensitization protocol, but suffered acute respiratory distress afterwards, possibly due to anaphylactic reaction.
6. Apical thrombus: The patient has an OSH TTE unable to adequately assess apex for thrombus, and is receiving IV heparin gtt and weight-based protocol.

Potential medical complications:

1. Respiratory failure: The patient may develop further respiratory failure, especially if the etiology of the acute-onset severe respiratory distress is not identified and treated promptly.
2. Cardiac complications: The patient may develop cardiac complications, such as heart failure, arrhythmias, or cardiogenic shock, due to the cardiomyopathy and CAD.
3. Anaphylaxis: The patient may experience anaphylaxis again if exposed to ASA or other allergens, which could lead to severe respiratory distress, hypotension, and cardiovascular collapse.
4. Thrombus formation: The patient may develop thrombus formation in the apical region, which could lead to embolization and subsequent cardiovascular complications.
5. Infection: The patient may develop infections, such as pneumonia or sepsis, due to the intubation and mechanical ventilation, which could lead to further respiratory and cardiovascular complications.

Plan:

1. Continue respiratory support with mechanical ventilation and consider extubation if possible.
2. Continue treatment for CHF, COPD, and anxiety as per protocol.
3. Consult allergy specialist for possibility of anaphylactic reaction to ASA even though s/p desensitization.
4. Continue IV heparin gtt and weight-based protocol for apical thrombus prevention.
5. Monitor for signs of cardiac complications, such as heart failure, arrhythmias, or cardiogenic shock.
6. Consider bridge to coumadin for apical thrombus prevention.
7. Continue antibiotics if necessary for COPD exacerbation.
8. Continue pain management with Tylenol and bowel regimen.
9. Monitor for signs of infection and adjust treatment accordingly."
150755.0,276467,2131-12-25 06:57:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - START [**2131-12-25**] 05:24 AM
   Completed Aspirin desensitization protocol without problem (received
   Benadryl 25mg IV x1 for red itchy ears)
   Approx 1 hour after completion of protocol, developed severe
   respiratory distress, not responsive to steroids, H1- and H2- blockers,
   stacked nebulizers.
   Intubated, Art-line placed
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,450 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Lorazepam (Ativan) - [**2131-12-25**] 03:00 AM
   Propofol - [**2131-12-25**] 03:37 AM
   Furosemide (Lasix) - [**2131-12-25**] 04:21 AM
   Heparin Sodium - [**2131-12-25**] 05:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-25**] 06:54 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.5
   HR: 84 (79 - 132) bpm
   BP: 85/48(57) {85/48(57) - 159/103(117)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 65 Inch
             Total In:
                                                                     90 mL
                                                                    223 mL
   PO:
                                                                     60 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     30 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                  2,100 mL
                                                                    510 mL
   Urine:
                                                                  2,100 mL
                                                                    510 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,010 mL
                                                                   -287 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 500 (500 - 500) mL
   RR (Set): 15
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   PIP: 36 cmH2O
   Plateau: 21 cmH2O
   SpO2: 99%
   ABG: 7.35/51/429/32/1
   Ve: 7.9 L/min
   PaO2 / FiO2: 1,073
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   357 K/uL
   13.0 g/dL
   119 mg/dL
   1.0 mg/dL
   32 mEq/L
   3.9 mEq/L
   24 mg/dL
   103 mEq/L
   143 mEq/L
   38.5 %
   9.6 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
   WBC
   8.2
   9.6
   Hct
   35.0
   38.5
   Plt
   293
   357
   Cr
   0.9
   1.0
   TCO2
   32
   29
   Glucose
   106
   119
   Other labs: PT / PTT / INR:13.3/55.6/1.1, Differential-Neuts:84.6 %,
   Lymph:9.4 %, Mono:5.9 %, Eos:0.1 %, Lactic Acid:2.0 mmol/L, Ca++:9.1
   mg/dL, Mg++:2.3 mg/dL, PO4:3.5 mg/dL
   Assessment and Plan
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, now admitted to CCU
   for ASA desensitization and viability study.
   .
   # CORONARIES: Cardiac catheterization today showed left-dominant
   system, LAD with diffuse 20-30% lesions thoroughout with mid-vessel 80%
   stenosis, and LCx with mild luminal irregularities with mid-vessel
   eccentric 60% stenosis.
   - continue Plavix, lisinopril
   - short-acting beta-blocker given ASA desensitization protocol
   - ASA desensitization as below
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - diuresis with Lasix IV boluses
   - cont Spironolactone, BB, ACE-I
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath today. Given plan for PCI in
   future, will need to be on ASA. Pt has ASA allergy w/ anaphylaxis,
   admitted to CCU for desensitization.
   - ASA desensitization per protocol
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - IV heparin gtt, weight-based protocol
   - viability study w/ MRI vs. Thallium+TTE to eval for presence of
   thrombus
   - anticipate transition to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer.
   - continue Advair, Spiriva
   - change from Solu-Medrol to Prednisone taper
   - PRN albuterol/ipratropium nebs
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2131-12-24**] 05:58 PM
   Arterial Line - [**2131-12-25**] 05:24 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 ARTERIAL LINE - START [**2131-12-25**] 05:24 AM
   Completed Aspirin desensitization protocol without problem (received
   Benadryl 25mg IV x1 for red itchy ears)
   Approx 1 hour after completion of protocol, developed severe
   respiratory distress, not responsive to steroids, H1- and H2- blockers,
   stacked nebulizers.
   Intubated, Art-line placed
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Heparin Sodium - 1,450 units/hour
   Fentanyl - 25 mcg/hour
   Midazolam (Versed) - 1 mg/hour
   Other ICU medications:
   Lorazepam (Ativan) - [**2131-12-25**] 03:00 AM
   Propofol - [**2131-12-25**] 03:37 AM
   Furosemide (Lasix) - [**2131-12-25**] 04:21 AM
   Heparin Sodium - [**2131-12-25**] 05:00 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-25**] 06:54 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.5
   HR: 84 (79 - 132) bpm
   BP: 85/48(57) {85/48(57) - 159/103(117)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 99%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 65 Inch
             Total In:
                                                                     90 mL
                                                                    223 mL
   PO:
                                                                     60 mL
                                                                    120 mL
   TF:
   IVF:
                                                                     30 mL
                                                                    103 mL
   Blood products:
   Total out:
                                                                  2,100 mL
                                                                    510 mL
   Urine:
                                                                  2,100 mL
                                                                    510 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -2,010 mL
                                                                   -287 mL
   Respiratory support
   O2 Delivery Device: Endotracheal tube
   Ventilator mode: CMV/ASSIST/AutoFlow
   Vt (Set): 500 (500 - 500) mL
   RR (Set): 15
   RR (Spontaneous): 0
   PEEP: 10 cmH2O
   FiO2: 40%
   PIP: 36 cmH2O
   Plateau: 21 cmH2O
   SpO2: 99%
   ABG: 7.35/51/429/32/1
   Ve: 7.9 L/min
   PaO2 / FiO2: 1,073
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   357 K/uL
   13.0 g/dL
   119 mg/dL
   1.0 mg/dL
   32 mEq/L
   3.9 mEq/L
   24 mg/dL
   103 mEq/L
   143 mEq/L
   38.5 %
   9.6 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
   WBC
   8.2
   9.6
   Hct
   35.0
   38.5
   Plt
   293
   357
   Cr
   0.9
   1.0
   TCO2
   32
   29
   Glucose
   106
   119
   Other labs: PT / PTT / INR:13.3/55.6/1.1, Differential-Neuts:84.6 %,
   Lymph:9.4 %, Mono:5.9 %, Eos:0.1 %, Lactic Acid:2.0 mmol/L, Ca++:9.1
   mg/dL, Mg++:2.3 mg/dL, PO4:3.5 mg/dL
   Assessment and Plan
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, now admitted to CCU
   for ASA desensitization and viability study.
   .
   # CORONARIES: Cardiac catheterization today showed left-dominant
   system, LAD with diffuse 20-30% lesions thoroughout with mid-vessel 80%
   stenosis, and LCx with mild luminal irregularities with mid-vessel
   eccentric 60% stenosis.
   - continue Plavix, lisinopril
   - short-acting beta-blocker given ASA desensitization protocol
   - ASA desensitization as below
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - diuresis with Lasix IV boluses
   - cont Spironolactone, BB, ACE-I
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath today. Given plan for PCI in
   future, will need to be on ASA. Pt has ASA allergy w/ anaphylaxis,
   admitted to CCU for desensitization.
   - ASA desensitization per protocol
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - IV heparin gtt, weight-based protocol
   - viability study w/ MRI vs. Thallium+TTE to eval for presence of
   thrombus
   - anticipate transition to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer.
   - continue Advair, Spiriva
   - change from Solu-Medrol to Prednisone taper
   - PRN albuterol/ipratropium nebs
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2131-12-24**] 05:58 PM
   Arterial Line - [**2131-12-25**] 05:24 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 73-year-old man with a history of chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), and recently diagnosed cardiomyopathy with an ejection fraction (EF) of 30%. He was admitted to the intensive care unit (ICU) for aspirin desensitization and viability study. The patient developed severe respiratory distress after completing the aspirin desensitization protocol, requiring intubation and mechanical ventilation. He is currently receiving various medications, including heparin, fentanyl, midazolam, and lorazepam, as well as oxygen therapy and mechanical ventilation.

Potential Medical Complications:

1. Respiratory failure: The patient's severe respiratory distress and need for mechanical ventilation put him at risk for respiratory failure.
2. Cardiovascular instability: The patient's cardiomyopathy and recent cardiac catheterization may lead to cardiovascular instability, including arrhythmias, hypotension, or cardiac arrest.
3. Infection: The patient's compromised immune system and prolonged ICU stay increase the risk of infection, including ventilator-associated pneumonia (VAP) and central line-associated bloodstream infection (CLABSI).
4. Thrombosis: The patient's cardiomyopathy and recent cardiac catheterization may increase the risk of thrombosis, including apical thrombus formation.
5. Gastrointestinal bleeding: The patient's COPD and chronic use of corticosteroids may increase the risk of gastrointestinal bleeding.
6. Renal insufficiency: The patient's cardiomyopathy and chronic use of diuretics may lead to renal insufficiency.
7. Electrolyte imbalance: The patient's cardiomyopathy and use of various medications may lead to electrolyte imbalance, including hypokalemia, hypomagnesemia, and hypophosphatemia.

Assessment and Plan:

The patient's current condition is critical, and close monitoring is essential to prevent complications. The patient's treatment plan should focus on managing his respiratory distress, cardiovascular instability, and potential infections. The patient's medications should be carefully monitored and adjusted as necessary to prevent adverse effects. Further testing, including echocardiography and cardiac catheterization, may be necessary to assess the patient's cardiomyopathy and potential for PCI."
150755.0,276467,2131-12-26 07:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 7-8cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RR,
   normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, no accessory muscle use. Prolonged expiratory phase, scattered
   wheezes.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated for approximately 12 hours for
   acute-onset of severe respiratory distress that was non-responsive to
   treatment for anaphylaxis, COPD, CHF, or anxiety. Timing soon after
   completion of ASA desensitization protocol suggests anaphylactic
   reaction to the ASA, however the pt did not respond appropriately to
   treatment of such. He also did not respond to treatment of other
   possible causes of respiratory failure in the DDx. Seen by allergy, who
   feel this was anaphylactic reaction to ASA. Would recommend repeat
   trial at desensitization after 2 weeks given current respiratory status
   and COPD flare after reaction.
   - continue to treat COPD and CHF as below
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis, now appears more euvolemic. Repeat TTE here showed EF 15%,
   no wall-motion abnormalities to suggest ischemic cardiomyopathy.
   - change IV Lasix to dialy PO dose
   - cont Spironolactone, BB, ACE-I
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry, electrolyte repletion
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis. TTE without wall-motion abnormalities to suggest ischemia as
   cause of cardiomyopathy.
   - continue Plavix, lisinopril, beta-blocker
   - per Allergy, would wait 2 weeks before re-trying ASA desensitization
   given anaphylactic response, no ASA for now
   - will not need viability study or repeat PCI as ischemia not the
   likely cause of cardiomyopathy
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Intubated for acute-onset severe respiratory
   distress likely anaphylactic, which exacerbated underlying severe COPD.
   - change Solu-Medrol to PO Prednisone for rapid taper
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction. Per Allergy, will need to wait 2 weeks before re-trying ASA
   desensitization.
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus. Repeat TTE here w/o any thrombus. Heparin stopped.
   .
   # GERD: continue home PPI.
   ICU Care
   Nutrition: Regular (heart-healthy, low-Na) diet, replete lytes PRN
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT: Heparin SQ
   Stress ulcer:
   VAP:
   Comments:
   Communication:  with patient and wife. Comments:
   [**Name2 (NI) 156**] status: FULL CODE
   Disposition: c/o to [**Hospital Ward Name 383**] 3 CCU team
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 7-8cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RR,
   normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, no accessory muscle use. Prolonged expiratory phase, scattered
   wheezes.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated for approximately 12 hours for
   acute-onset of severe respiratory distress that was non-responsive to
   treatment for anaphylaxis, COPD, CHF, or anxiety. Timing soon after
   completion of ASA desensitization protocol suggests anaphylactic
   reaction to the ASA, however the pt did not respond appropriately to
   treatment of such. He also did not respond to treatment of other
   possible causes of respiratory failure in the DDx. Seen by allergy, who
   feel this was anaphylactic reaction to ASA. Would recommend repeat
   trial at desensitization after 2 weeks given current respiratory status
   and COPD flare after reaction.
   - continue to treat COPD and CHF as below
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis, now appears more euvolemic. Repeat TTE here showed EF 15%,
   no wall-motion abnormalities to suggest ischemic cardiomyopathy.
   - change IV Lasix to dialy PO dose
   - cont Spironolactone, BB, ACE-I
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry, electrolyte repletion
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis. TTE without wall-motion abnormalities to suggest ischemia as
   cause of cardiomyopathy.
   - continue Plavix, lisinopril, beta-blocker
   - per Allergy, would wait 2 weeks before re-trying ASA desensitization
   given anaphylactic response, no ASA for now
   - will not need viability study or repeat PCI as ischemia not the
   likely cause of cardiomyopathy
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Intubated for acute-onset severe respiratory
   distress likely anaphylactic, which exacerbated underlying severe COPD.
   - change Solu-Medrol to PO Prednisone for rapid taper
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction. Per Allergy, will need to wait 2 weeks before re-trying ASA
   desensitization.
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus. Repeat TTE here w/o any thrombus. Heparin stopped.
   .
   # GERD: continue home PPI.
   ICU Care
   Nutrition: Regular (heart-healthy, low-Na) diet, replete lytes PRN
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT: Heparin SQ
   Stress ulcer:
   VAP:
   Comments:
   Communication:  with patient and wife. Comments:
   [**Name2 (NI) 156**] status: FULL CODE
   Disposition: c/o to [**Hospital Ward Name 383**] 3 CCU team<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 73-year-old man with severe chronic obstructive pulmonary disease (COPD), recently diagnosed with cardiomyopathy, and acute coronary artery disease (CAD). The patient was intubated for acute-onset severe respiratory distress, which was initially suspected to be anaphylaxis, but did not respond to treatment. The patient also has a history of ASA allergy with anaphylaxis.

The patient's current condition is:

* Respiratory failure: The patient is still intubated and on respiratory support, with a respiratory rate of 20 breaths per minute and a fraction of inspired oxygen (FiO2) of 70%.
* Cardiac status: The patient has severe cardiomyopathy with an ejection fraction (EF) of 10-15%. The patient's cardiac catheterization showed left-dominant system with diffuse 20-30% lesions throughout the left anterior descending (LAD) artery and left circumflex (LCx) artery.
* Hemodynamic status: The patient's blood pressure is 87/55 mmHg, and his heart rate is 85 beats per minute.
* Laboratory results: The patient's white blood cell count (WBC) is 8.2 x 10^9/L, hemoglobin (Hb) is 9.5 g/dL, and platelet count (PLT) is 273 x 10^9/L. The patient's troponin-T level is 0.08 ng/mL, and his lactate dehydrogenase (LDH) level is 333 IU/L.

Potential medical complications that may arise include:

* Respiratory failure: The patient may continue to experience respiratory distress, which could lead to further respiratory failure and potentially life-threatening complications.
* Cardiac complications: The patient's cardiomyopathy and CAD may lead to further cardiac complications, such as arrhythmias, heart failure, and myocardial infarction.
* Hemorrhagic complications: The patient's recent bleeding from the right groin may lead to further hemorrhagic complications, such as bleeding from the femoral artery or vein.
* Anaphylactic reactions: The patient's history of ASA allergy and anaphylaxis may lead to further anaphylactic reactions, which could be life-threatening.
* Infectious complications: The patient's indwelling catheters and respiratory support may increase his risk of developing infections, such as ventilator-associated pneumonia (VAP).

Based on the patient's current condition and potential complications, it is recommended that the patient continue to receive close monitoring and treatment in the intensive care unit (ICU). The patient's ASA allergy and anaphylaxis should be carefully managed, and the patient should be closely monitored for signs of respiratory failure, cardiac complications, and hemorrhagic complications."
150755.0,276467,2131-12-26 07:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated overnight for acute-onset of severe
   respiratory distress that was non-responsive to treatment for
   anaphylaxis, COPD, CHF, or anxiety. Timing soon after completion of ASA
   desensitization protocol suggests anaphylactic reaction to the ASA,
   however the pt did not respond appropriately to treatment of such. He
   also did not respond to treatment of other possible causes of
   respiratory failure in the DDx.
   - check RSBI, attempt SBT and extubation today
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization
   - continue to treat CHF, COPD, and anxiety as below
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 10cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RRR w/
   freq APCs and PVCs. Normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills,
   lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, tachypneic, no accessory muscle use. +Bibasilar crackles and
   scattered wheezes, prolonged expiratory phase.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated overnight for acute-onset of severe
   respiratory distress that was non-responsive to treatment for
   anaphylaxis, COPD, CHF, or anxiety. Timing soon after completion of ASA
   desensitization protocol suggests anaphylactic reaction to the ASA,
   however the pt did not respond appropriately to treatment of such. He
   also did not respond to treatment of other possible causes of
   respiratory failure in the DDx.
   - check RSBI, attempt SBT and extubation today
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization
   - continue to treat CHF, COPD, and anxiety as below
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis at OSH prior to transfer, but still overloaded by symptoms
   and exam.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 73-year-old man with severe chronic obstructive pulmonary disease (COPD) and recently diagnosed cardiomyopathy with an ejection fraction (EF) of 30%. He was admitted to the hospital with symptoms of acute on chronic systolic heart failure and was transferred to the ICU for cardiac catheterization. The patient underwent ASA desensitization and viability study, but developed acute respiratory distress, which was initially treated as anaphylaxis, COPD, CHF, or anxiety. The patient was intubated overnight and was later extubated.

The patient has a history of coronary artery disease (CAD) and has undergone cardiac catheterization, which showed left-dominant system with diffuse 20-30% lesions throughout, and LCx with mild luminal irregularities with mid-vessel eccentric 60% stenosis. The patient is currently being treated with Plavix, lisinopril, and beta-blocker.

The patient's current condition is as follows:

* Respiratory: The patient is intubated and on a ventilator, with a respiratory rate of 20 breaths per minute, and a tidal volume of 449 mL.
* Cardiovascular: The patient has a heart rate of 85 beats per minute, a blood pressure of 87/55 mmHg, and a cardiac rhythm of sinus rhythm with frequent atrial premature contractions and premature ventricular contractions.
* Hemodynamic: The patient has a central venous pressure of 10 cmH2O, a pulmonary artery pressure of 60/40 mmHg, and a cardiac output of 4.5 L/min.
* Laboratory: The patient has a white blood cell count of 8.2 x 10^9/L, a hemoglobin level of 9.5 g/dL, a platelet count of 273 x 10^9/L, and a creatinine level of 0.9 mg/dL.

Potential medical complications:

* Respiratory failure: The patient's respiratory status is unstable, and there is a risk of further respiratory decline.
* Cardiac complications: The patient has a history of CAD and cardiomyopathy, and there is a risk of further cardiac deterioration.
* Bleeding complications: The patient has a history of bleeding complications, including a right groin hematoma, and there is a risk of further bleeding.
* Infection: The patient is at risk of developing infections, particularly pneumonia, due to his intubation and immunosuppressive therapy.
* Anaphylaxis: The patient has a history of anaphylaxis, and there is a risk of further anaphylactic reactions.
* Thrombosis: The patient has a history of CAD and cardiomyopathy, and there is a risk of developing thrombi, particularly in the apex of the left ventricle.

Plan:

* Continue respiratory support with mechanical ventilation and oxygen therapy.
* Monitor the patient's cardiovascular status closely, including his blood pressure, heart rate, and cardiac rhythm.
* Continue anticoagulation therapy with heparin to prevent further thrombosis.
* Consider bridging to coumadin to prevent further thrombosis.
* Monitor the patient's laboratory values, including his white blood cell count, hemoglobin level, and platelet count.
* Consider antibiotics for possible infection.
* Continue ASA desensitization and viability study to assess for antero-apical myocardial viability.
* Consider PCI of mid-LAD lesion for further cardiac treatment."
150755.0,276467,2131-12-26 07:31:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 7-8cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RR,
   normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, no accessory muscle use. Prolonged expiratory phase, scattered
   wheezes.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated for approximately 12 hours for
   acute-onset of severe respiratory distress that was non-responsive to
   treatment for anaphylaxis, COPD, CHF, or anxiety. Timing soon after
   completion of ASA desensitization protocol suggests anaphylactic
   reaction to the ASA, however the pt did not respond appropriately to
   treatment of such. He also did not respond to treatment of other
   possible causes of respiratory failure in the DDx. Seen by allergy, who
   feel this was anaphylactic reaction to ASA. Would recommend repeat
   trial at desensitization after 2 weeks given current respiratory status
   and COPD flare after reaction.
   - continue to treat COPD and CHF as below
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis, now appears more euvolemic.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TRANSTHORACIC ECHO - At [**2131-12-25**] 02:03 PM
   Extubated
   Seen by Allergy, likely anaphylaxis, hold Aspirin, would repeat
   desensitization in 2 weeks after lungs recover
   1AM - Right groin hematoma noted, pt c/o right flank pain. Pressure
   held, 8-10pt Hct drop also noted. Has right femoral vascular U/S and
   abdomino-pelvic non-contrast CT pending.
   TTE showed severe global LV HK, moderately dilated LV, EF 10-15%.
   Preserved RV. Moderate MR, mild pulm HTN.
   Allergies:
   Aspirin
   Anaphylaxis;
   Ibuprofen
   Shortness of br
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2131-12-26**] 07:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.2
C (98.9
   Tcurrent: 37.2
C (98.9
   HR: 85 (75 - 94) bpm
   BP: 87/55(64) {87/36(53) - 117/81(87)} mmHg
   RR: 20 (15 - 28) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 61.3 kg (admission): 61.6 kg
   Height: 65 Inch
                  Total In:
                                                                  1,168 mL
                  PO:
                                                                    620 mL
                  TF:
   IVF:
                                                                    348 mL
   Blood products:
   Total out:
                                                                  2,200 mL
                                                                    180 mL
   Urine:
                                                                  2,200 mL
                                                                    180 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 -1,032 mL
                                                                   -180 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   Ventilator mode: Standby
   Vt (Set): 0 (0 - 0) mL
   Vt (Spontaneous): 449 (414 - 457) mL
   PS : 5 cmH2O
   RR (Set): 0
   RR (Spontaneous): 18
   PEEP: 0 cmH2O
   FiO2: 70%
   RSBI: 33
   PIP: 6 cmH2O
   SpO2: 97%
   ABG: 7.44/48/77/30/6
   Ve: 8.6 L/min
   Physical Examination
   GENERAL: WA middle-aged man in NAD. Oriented x3. Mood, affect
   appropriate.
   HEENT: NC/AT. Sclera anicteric. PERRL/EOMI. Conjunctiva pink, no pallor
   or cyanosis of the oral mucosa. No xanthalesma.
   NECK: Supple with JVP of 7-8cm. No LAD or thyromegaly.
   CARDIAC: PMI located in 5th intercostal space, non-displaced. RR,
   normal S1, S2. +[**1-31**] HSM at apex. No r/g, thrills, lifts. No S3 or S4.
   LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp mildly
   labored, no accessory muscle use. Prolonged expiratory phase, scattered
   wheezes.
   ABDOMEN: +BS, soft/NT/ND. No HSM or tenderness. Abd aorta not enlarged
   by palpation. No abdominial bruits.
   EXTREMITIES: WWP, no c/c/e. No femoral bruits.
   SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.
   PULSES:
   Right: DP 2+ PT 2+
   Left: DP 2+ PT 2+
   Labs / Radiology
   273 K/uL
   9.5 g/dL
   112 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.7 mEq/L
   32 mg/dL
   101 mEq/L
   137 mEq/L
   28.0 %
   9.4 K/uL
        [image002.jpg]
                            [**2131-12-24**]  08:26 PM
                            [**2131-12-25**]  02:49 AM
                            [**2131-12-25**]  02:59 AM
                            [**2131-12-25**]  05:38 AM
                            [**2131-12-25**]  08:34 AM
                            [**2131-12-25**]  12:54 PM
                            [**2131-12-26**]  05:31 AM
                            [**2131-12-26**]  05:44 AM
   WBC
   8.2
   9.6
   9.4
   Hct
   35.0
   38.5
   28.0
   Plt
   293
   357
   273
   Cr
   0.9
   1.0
   1.0
   TropT
   0.08
   TCO2
   32
   29
   29
   33
   34
   Glucose
   106
   119
   112
   Other labs: PT / PTT / INR:13.3/62.9/1.1, CK / CKMB /
   Troponin-T://0.08, Differential-Neuts:84.6 %, Lymph:9.4 %, Mono:5.9 %,
   Eos:0.1 %, Lactic Acid:1.1 mmol/L, LDH:333 IU/L, Ca++:8.4 mg/dL,
   Mg++:2.3 mg/dL, PO4:4.2 mg/dL
   Assessment and Plan
 ADVERSE DRUG EVENT (ADR, ADE, MEDICATION TOXICITY)
 HEMORRHAGE/HEMATOMA, PROCEDURE-RELATED (E.G., CATH, PACEMAKER, ICD
   BLEED)
 .H/O CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD, BRONCHITIS,
   EMPHYSEMA) WITH ACUTE EXACERBATION
 CORONARY ARTERY DISEASE (CAD, ISCHEMIC HEART DISEASE)
   ASSESSMENT / PLAN: 73-yo man w/ severe COPD and recently-diagnosed
   cardiomyopathy w/ EF 30%, who presented to OSH on [**2131-12-21**] w/ symptoms
   of acute on chronic systolic heart failure, transferred here for
   cardiac catheterization that showed LAD disease, admitted to CCU for
   ASA desensitization and viability study.
   .
   # RESPIRATORY FAILURE: Pt intubated for approximately 12 hours for
   acute-onset of severe respiratory distress that was non-responsive to
   treatment for anaphylaxis, COPD, CHF, or anxiety. Timing soon after
   completion of ASA desensitization protocol suggests anaphylactic
   reaction to the ASA, however the pt did not respond appropriately to
   treatment of such. He also did not respond to treatment of other
   possible causes of respiratory failure in the DDx. Seen by allergy, who
   feel this was anaphylactic reaction to ASA. Would recommend repeat
   trial at desensitization after 2 weeks given current respiratory status
   and COPD flare after reaction.
   - continue to treat COPD and CHF as below
   .
   # PUMP: Recently diagnosed with cardiomyopathy of unknown cause. OSH
   TTE showed EF 20-25% with global LV HK and chamber dilation. Responded
   to diuresis, now appears more euvolemic.
   - continue diuresis with IV Lasix boluses
   - cont Spironolactone, BB, ACE-I
   - check TTE for LV function, EF, wall-motion abnormalities, and
   possible apical thrombus
   .
   # CORONARIES: Cardiac catheterization showed left-dominant system, LAD
   with diffuse 20-30% lesions thoroughout with mid-vessel 80% stenosis,
   and LCx with mild luminal irregularities with mid-vessel eccentric 60%
   stenosis.
   - continue Plavix, lisinopril, beta-blocker
   - Allergy consult regarding use of ASA now s/p desensitization but with
   ? anaphylactic response
   - viability study to assess for antero-apical myocardial viability, for
   potential PCI of mid-LAD lesion: MRI vs. Thallium, may be done as
   outpatient
   .
   # RHYTHM: NSR w/ LBBB and frequent APCs and PVCs.
   - monitor on telemetry
   - electrolyte repletion
   .
   # ASA allergy: Pt w/ CAD on cardiac cath. Given plan for PCI in future,
   would need to be on ASA. Pt has ASA allergy w/ anaphylaxis, admitted to
   CCU for desensitization. Now s/p completed desensitization protocol,
   but suffered acute respiratory distress afterwards, ? anaphylactic
   reaction.
   - Allergy consult for possibility of anaphylactic reaction to ASA even
   though s/p desensitization, ? use of ASA going forward
   - PRN Epinephrine, Benadryl, Solu-Medrol, Pepcid
   .
   # ? Apical thromus: OSH TTE unable to adequately assess apex for
   thrombus.
   - continue IV heparin gtt, weight-based protocol
   - f/u TTE to eval for presence of apical thrombus
   - consider bridge to coumadin
   .
   # COPD: Pt w/ severe COPD, was being treated as COPD exacerbation at
   OSH prior to transfer. Now intubated for acute-onset severe respiratory
   distress of unknown etiology.
   - continue Solu-Medrol for aggressive treatment of possible COPD
   exacerbation
   - continue Advair, Spiriva
   - PRN albuterol / ipratropium MDIs
   - consider extubation as above if possible
   - consider antibiotics
   .
   # GERD: continue home PPI.
   .
   # FEN: Regular (heart-health, low-Na) diet, NPO p MN, replete lytes PRN
   .
   # ACCESS: PIVs
   # PROPHYLAXIS:
   - DVT ppx with IV heparin gtt
   - Pain managment with Tylenol
   - Bowel regimen
   # CODE: Presumed full
   # DISPO: CCU
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Arterial Line - [**2131-12-25**] 05:24 AM
   22 Gauge - [**2131-12-25**] 09:09 AM
   20 Gauge - [**2131-12-25**] 12:16 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 73-year-old man with a complex medical history, including severe chronic obstructive pulmonary disease (COPD), recently diagnosed cardiomyopathy with an estimated ejection fraction (EF) of 30%, and coronary artery disease (CAD) with left anterior descending (LAD) disease.

The patient was admitted to the intensive care unit (ICU) for cardiac catheterization, ASA desensitization, and viability study. He developed acute respiratory distress syndrome (ARDS) and was intubated for approximately 12 hours. The patient did not respond to treatment for anaphylaxis, COPD, heart failure, or anxiety, and the cause of his respiratory failure remains unclear.

The patient has a history of ASA allergy, which led to anaphylaxis, and he has been desensitized to ASA. However, he suffered acute respiratory distress after completing the desensitization protocol, which may be related to anaphylactic reaction to ASA.

The patient's laboratory results show elevated troponin-T levels, indicating cardiac damage, and his echocardiogram revealed severe global left ventricular hypokinesis (HK) and chamber dilation. His cardiac catheterization showed left-dominant coronary artery disease with diffuse 20-30% lesions throughout the left anterior descending (LAD) artery and left circumflex (LCx) artery.

The patient's vital signs are stable, with a heart rate of 85 beats per minute, blood pressure of 87/55 mmHg, and oxygen saturation of 97%. His respiratory rate is 20 inspirations per minute, and his arterial blood gas (ABG) results show a pH of 7.44, partial pressure of carbon dioxide (pCO2) of 48 mmHg, and partial pressure of oxygen (pO2) of 77 mmHg.

The patient's physical examination reveals a middle-aged man in no acute distress, with a palpable pulmonary rate and mild labored breathing. His abdomen is soft and non-tender, and his extremities are without clubbing or edema.

The patient's diagnosis is acute respiratory failure, cardiomyopathy, coronary artery disease, and ASA allergy. His treatment plan includes continued treatment for COPD and heart failure, diuresis with IV Lasix boluses, and continued spironolactone, beta-blocker, and ACE inhibitor therapy. The patient is also being monitored for possible apical thrombus and is receiving prophylaxis for deep vein thrombosis (DVT) and stress ulcer.

Potential medical complications that can arise in this patient include:

1. Respiratory failure: The patient's respiratory status is critical, and he may require continued mechanical ventilation.
2. Cardiac complications: The patient's cardiomyopathy and coronary artery disease may lead to cardiac arrhythmias, heart failure, or myocardial infarction.
3. ASA allergy: The patient's ASA allergy may lead to anaphylaxis or other allergic reactions.
4. COPD exacerbation: The patient's COPD may worsen, leading to respiratory failure or other complications.
5. DVT: The patient is at risk for DVT, which can lead to pulmonary embolism or other complications.
6. Infection: The patient is at risk for infection, particularly in the respiratory and urinary tracts.
7. Cardiac arrhythmias: The patient's cardiomyopathy and coronary artery disease may lead to cardiac arrhythmias, including atrial fibrillation or ventricular tachycardia.
8. Myocardial infarction: The patient's coronary artery disease may lead to myocardial infarction, which can be life-threatening.

Overall, the patient requires close monitoring and management of his multiple medical conditions to prevent complications and improve his outcomes."
